Alleviate Health
-81%
est. 2Y upside i
Clinical trials recruitment is the largest bottleneck in drug development and site revenue growth. Alleviate Health accelerates recruitment speed with conversational AI that pre-screens patients over SMS that allows sites to drastically improve their output.
Rank
#44
Sector
HealthTech, Artificial Intelligence
Est. Liquidity
~5Y
Data Quality
Data: MediumAlleviate Health presents a high-risk, high-reward equity opportunity given its early stage, strong investor backing, and impressive initial traction in a critical healthcare niche.
Last updated: February 16, 2026
Alleviate Health achieves rapid market penetration and secures a substantial Series B funding round at a significantly increased valuation, potentially expanding into new therapeutic areas or geographies.
The company continues its strong growth, successfully scales its operations, and raises a well-received Series A round, solidifying its position in the patient recruitment market.
Scaling challenges emerge, incumbent healthcare tech providers integrate similar AI solutions, or market adoption of AI tools in healthcare slows due to maturity concerns, leading to a flat or slightly reduced valuation.
Operations Staff — 2 roles
- Business Operations · San Francisco
- Customer Success Manager · San Francisco
Sales & GTM Staff — 1 role
- Account Executive · San Francisco
Technical Staff — 1 role
- Founding Engineer · San Francisco
Last updated: March 10, 2026
Community
Valuation Sentiment
Our model estimates -81% upside. What do you think?
Anonymous. Do not share material non-public information.
Community Discussion
Comments are reviewed before they appear publicly.
Loading comments...
Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.